CN202096333U - In utero active contraceptive device for animal - Google Patents
In utero active contraceptive device for animal Download PDFInfo
- Publication number
- CN202096333U CN202096333U CN2011201245991U CN201120124599U CN202096333U CN 202096333 U CN202096333 U CN 202096333U CN 2011201245991 U CN2011201245991 U CN 2011201245991U CN 201120124599 U CN201120124599 U CN 201120124599U CN 202096333 U CN202096333 U CN 202096333U
- Authority
- CN
- China
- Prior art keywords
- utero
- animal
- alloy wire
- contraceptive device
- active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241001465754 Metazoa Species 0.000 title claims abstract description 28
- 210000004291 uterus Anatomy 0.000 title claims abstract description 24
- 230000002254 contraceptive effect Effects 0.000 title abstract description 19
- 239000003433 contraceptive agent Substances 0.000 title abstract description 16
- 229910001000 nickel titanium Inorganic materials 0.000 claims abstract description 29
- 239000010949 copper Substances 0.000 claims abstract description 23
- 229910052802 copper Inorganic materials 0.000 claims abstract description 23
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229910045601 alloy Inorganic materials 0.000 claims description 24
- 239000000956 alloy Substances 0.000 claims description 24
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 24
- 235000010603 pastilles Nutrition 0.000 claims description 8
- 238000009432 framing Methods 0.000 claims description 4
- 125000006850 spacer group Chemical group 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 8
- 230000002441 reversible effect Effects 0.000 abstract description 5
- 239000003814 drug Substances 0.000 abstract description 4
- 238000006073 displacement reaction Methods 0.000 abstract description 2
- 239000003163 gonadal steroid hormone Substances 0.000 abstract description 2
- 239000005556 hormone Substances 0.000 abstract description 2
- 229940088597 hormone Drugs 0.000 abstract description 2
- 210000000056 organ Anatomy 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 230000035935 pregnancy Effects 0.000 abstract 1
- 230000003248 secreting effect Effects 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
- 241000282472 Canis lupus familiaris Species 0.000 description 9
- 210000003679 cervix uteri Anatomy 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 238000004659 sterilization and disinfection Methods 0.000 description 6
- 241000282326 Felis catus Species 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000002980 postoperative effect Effects 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 239000003984 copper intrauterine device Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000007086 side reaction Methods 0.000 description 2
- 210000001215 vagina Anatomy 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 208000008067 Intrauterine Device Expulsion Diseases 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001425718 Vagrans egista Species 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 230000027326 copulation Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002357 endometrial effect Effects 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 230000012173 estrus Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002443 multiload copper intrauterine device Substances 0.000 description 1
- 208000025661 ovarian cyst Diseases 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
Images
Landscapes
- Orthopedics, Nursing, And Contraception (AREA)
Abstract
An in utero active contraceptive device for animal comprises a V-shaped nickel-titanium alloy wire frame. The in utero active contraceptive device is technically characterized in that: two ends of the V-shaped nickel-titanium alloy wire frame are respectively provided with a spacing copper cap; and the V-shaped nickel-titanium alloy wire frame is also separately provided with a copper sleeve and a tubular medicine-containing sustained releasing member. The in utero active contraceptive device for animal is advantageous in that: no damage or open wound is caused for the animal; the in utero active contraceptive device accords with a cherishing mentality of a pet owner for the pet; the contraceptive effect is remarkable and safe; and the method is a reversible contraceptive method. No extirpation for in utero sex hormone secretory organ is required thereby causing no effect for normal hormone level in the animal body. A contraceptive device frame is used for providing excellent biological compatibility. A memory nickel-titanium alloy wire causes a remarkable rule in loading an in vitro contraceptive device and expanding the in utero contraceptive device. An original design state is kept. Deformation and downward displacement and shedding hardly occur thereby obtaining an excellent contraceptive function. Particularly the in utero active contraceptive device for animal has a remarkable effect for preventing accidental pregnancy caused by falling-off of the contraceptive device.
Description
Technical field
This utility model relates to animal contraceptive techniques field, specifically a kind of in utero active birth control apparatus of animal that animal is adopted reversible birth control mode.
Background technology
Along with Chinese society's rapid economy development, the selection pet feeding that People more and more is many is accompanied the life of oneself.China just has since ancient times dotes on the custom of supporting dog and cat, and existing pet dog nowadays and cat also account for absolute big ratio in all house pets.
According to reports of official resources, the domestic existing pet dog quantity of China has reached 1.5 hundred million, is equivalent to per 9 Chinese and just supports a pet dog.On average there are 100,000 Canis familiaris L.s in each city, and is annual also with 10,000 speed increment.At present the pet dog quantity of Beijing public security bureau registration reach 50 surplus ten thousand, the actual quantity of raising is above 1,000,000.
Nowadays, the problem of pet dog excessive multiplication has caused society and certain concern in the domestic city.According to calculating, the pet cat of a pair of health, in 7 years no any control carry out copulation, its descendants's accumulated quantity can be above 300,000.The situation of pet dog is as the same.With Beijing is example, and the house pet quantity of roaming about has according to incompletely statistics reached 1,000,000.Owing to the excessive multiplication of house pet causes a large amount of vagrant animals, all society has been caused great burden from urban construction, management of markets in urban districts to aspects such as animal ethics, if or else pay attention to, will cause serious social concern.
For pet dog or cat, the method for carrying out birth control or sterillization has following several kinds at present:
1, sterilization operation: male is male castration, and female is uterus and oophorectomize;
2, ligation;
3, contraception medicament;
4, induced abortion is conceived finally.
In above several method, sterilization operation is the method for the most often taking, and other several method is because basic few use of a variety of causes.And be to take the way of extracing the uterus or uterus and ovary being extractd simultaneously to the sterilization operation of female house pet, the strengths and weaknesses of jenny sterilization operation is distinguished as follows:
Advantage: 1, disposable solution sterillization problem, do not recur;
2, the postoperative jenny no longer includes oestrus, feeds to owner to bring convenience;
3, can stop diseases such as the common ovarian cyst of jenny, mammary neoplasms;
Shortcoming: 1, operation is open, can stay the wound of wound;
2, to jenny, will upset animal body internal hormone secretion level after ovary picked-off, cause the postoperative animal do not like motion, gluttonous, to phenomenons such as surrounding sensitivity reductions, abnormally fat phenomenon appears;
3, the influence of operation is irreversible, and the postoperative animal can not give birth to once more;
4, for the house pet of some famous and precious kinds, sterilization operation is a kind of very serious loss;
5, level is uneven in the industry, and operation level and tariff level difference are also bigger;
6, pet owners at heart the house pet of often difficult acceptance oneself do sterilization operation;
As everyone knows, human intrauterine device (IUD) is good, safe, easy to use, economic, the reversible long-acting contraception method of a kind of contraceptive effect.The use of intrauterine device is in China's history of existing decades, for huge contribution has been made in China's family planning work.At present, nearly 1.04 hundred million people of China use, and commonly used have Tcu380A, Tcu220C, MLcu375, palace cu300 and an active V-type TUD.And the intrauterine device of using for animal (house pet) does not specially see also that at present report is arranged.
Summary of the invention
The purpose of this utility model provides a kind of in utero active birth control apparatus of animal that animal is adopted reversible birth control mode.
The purpose of this utility model is achieved in that it includes the nitinol alloy wire skeleton of a V-arrangement; It is characterized in that: be respectively arranged with a spacing copper medicated cap in two ends of V-arrangement nitinol alloy wire skeleton, on V-arrangement nitinol alloy wire skeleton, go back spacer sleeve copper sheathing and tubulose pastille slow-release body are housed.
This novel afterbody that also is included in V-arrangement nitinol alloy wire skeleton also is provided with a spacing divider through the tailfiber connection.
Above-mentioned V-arrangement nitinol alloy wire skeleton is shuttle type framing structure or three-dimensional cup-shaped framing structure.
This utility model structure and contraception principle:
1, structure comprises that commentaries on classics on nitinol alloy wire skeleton and the skeleton joins thing and form, and assemblage comprises copper sheathing, copper medicated cap, pastille slow-release body etc.
2, structure is divided into head and afterbody two ends, and head is two ends of V-arrangement nitinol alloy wire skeleton upper shed and respectively joins a copper medicated cap, the acting as of this copper medicated cap: one, increase the surface area of copper, and make contraception more reliable; Two, for birth control apparatus gets into the cervix uteri mouth slick, a sizeable contact surface is provided, avoid the cervix uteri mouth is damaged.
3, the effect of copper sheathing and copper medicated cap (contraception principle): the copper ion that metallic copper discharges through the oxidation corrosion in cavity of uterus disturbs the interior environment in the cavity of uterus, is unfavorable for implantation of ovum, plays contraceptive efficacy.
4, the effect of pastille slow-release body: one, the antibiotic medicine alleviates the inflammation at band device initial stage, pain, the incidence rate of phenomenon such as hemorrhage is significantly improved the side reaction of irregular menstruation behind the band device; Two, steroid hormone (progesterone etc.) makes the local change of endometrium; Can obviously suppress endometrial growth; Make the cervical mucus retrogradation be unfavorable for that sperm penetrates, stop sperm in uterine cavity and intratubal activity, minority suppresses ovulation and waits summation loop and reach contraception.
5, at the birth control apparatus afterbody of V-arrangement nitinol alloy wire skeleton, can fasten tailfiber, and connect a spacing divider.Its effect is: 1., when taking out birth control apparatus, the birth control apparatus position is confirmed; 2., spacing divider can prevent that birth control apparatus is excessively mobile toward the depths, uterus; 3., as required, on spacing divider, the copper medicated cap is installed equally or/and tubulose pastille slow-release body etc. contraceptions active substance, strengthens the contraceptive efficacy of birth control apparatus.Tailfiber and stop are not necessary.
Advantage of this utility model and characteristics:
1, starts the new method of house pet birth control, changed the thinking and the pattern of traditional house pet birth control; For city roam house pet quantity controls, improves the house pet living benefits, the reinforcement administration of city appearance provides an effective solution.
2, house pet is not had wound, have no initiative wound, meet the psychology of pet owners love house pet.
3, contraceptive effect is obvious, safety.
4, this method is reversible method of birth control, after promptly birth control apparatus is extractd, recovers through a period of time, and house pet still can give birth to.
5, need not extract animal sex hormone secretion in vivo organ, so normal hormonal readiness in the animal body is not had influence.
6, use as the birth control apparatus skeleton, superior biocompatibility is provided; The memory nitinol alloy wire loads external birth control apparatus and the interior birth control apparatus of body launches to be evident regularity.Keep original design form, not yielding, downward displacement comes off, thereby reaches good contraceptive efficacy, particularly prevent since iud expulsion cause unexpected pregnant aspect significant effect is arranged.
7, use the pastille slow-release body contain the anti-inflammatory type medicine, reduce the inflammation of wearing the birth control apparatus initial stage, pain, hemorrhage etc. existing
The incidence rate of elephant.
8, the surface area of birth control apparatus sized, copper product etc. can be adjusted according to practical situation, more meets different builds sizes
The practical situation of animal.In addition, significantly reduce the expense of house pet method of birth control in the past.
Advantages such as that this utility model also has is simple in structure, be convenient to operation, safe and reliable, and side effect is little, integrated cost is low.
Description of drawings
Fig. 1 is the sectional structure simplified schematic diagram of this utility model;
Fig. 2 is the user mode structural representation sketch of Fig. 1;
Fig. 3 is the application structure sketch of this utility model.
To combine accompanying drawing this utility model to be done further explain below through instance; But following instance only is this utility model example wherein; The rights protection scope of not representing this utility model and being limited, the rights protection scope of this utility model is as the criterion with claims.
The specific embodiment
Shown in Fig. 1～3; What 1 among the figure selected for use is that diameter is the nitinol alloy wire skeleton of 0.15-0.8mm; The nitinol alloy wire of this structure has memory characteristic: nitinol alloy wire has reasonable elasticity when a temperature of setting is following, can carry out crooked largely and folding.And on ambient temperature rises to design temperature the time, the recovering state of nitinol alloy wire is a design form, and intensity increases, and is not yielding; The nitinol alloy wire of being bought need pass through certain heat treatment process, and the design form that makes it is the unfoldable shape of ambient temperature when being higher than design temperature; And under the lower state of temperature, because nickel-titanium alloy framework has better elasticity and morphotropism, can it be compressed in the inserter sleeve pipe.
Manufacture method:
Earlier nitinol alloy wire is put into the fixedly mould of usefulness, through the memory characteristic of certain heat treatment process animal training with the birth control apparatus skeleton.The form of grinding tool is skeleton complete unfolded design shape in animal uterus, and the temperature that skeleton reverts to design form fully is no more than 37
oC.
After V-arrangement nitinol alloy wire skeleton 1 forms, on this nitinol alloy wire skeleton 1, be set with copper sheathing 2, tubulose pastille slow-release body 3 also is assemblied on this skeleton simultaneously; The head end of nitinol alloy wire skeleton 1 is entangled fixing with copper medicated cap 5; As required, the afterbody end is fastened tailfiber, fastens tailfiber 6 at the afterbody of V-arrangement nitinol alloy wire skeleton, and the tailfiber other end is connected with a spacing divider 7, and is excessively mobile to the depths, uterus to prevent birth control apparatus, in addition, and same shell-like copper medicated cap 8 on the divider 7 on the throne; The birth control apparatus that assembles is packed in the inserter 4.
Animal is used the intrauterine device laying method:
1. the vaginal dilator that uses size to be fit to expands the animal vagina to be opened, and the degree of depth is clearly seeing that the cervix uteri mouth in uterus 9 is as the criterion;
2. the inserter that will be loaded with birth control apparatus stretches into vagina, and the front end of inserter is that head end copper medicated cap 5 is aimed at the cervix uteri mouth;
3. promote the motion bar at inserter rear, the copper medicated cap of a birth control apparatus head exposes; Adjust the position then, the copper medicated cap is put into the cervix uteri mouth earlier;
4. continue to promote motion bar with suitable dynamics, whole birth control apparatus is pushed in the cervix uteri mouth;
5. as tailfiber or stop need to be installed, then need before above operation, tailfiber and stop to be connected, put back in the inserter again.
This utility model side reaction in use is identical with the use of human birth control apparatus, can improve fully through self material, technology, shape, the performance of optimizing birth control apparatus.
Claims (4)
1. in utero active birth control apparatus of animal; It includes the nitinol alloy wire skeleton of a V-arrangement; It is characterized in that: be respectively arranged with a spacing copper medicated cap in two ends of V-arrangement nitinol alloy wire skeleton, on V-arrangement nitinol alloy wire skeleton, go back spacer sleeve copper sheathing and tubulose pastille slow-release body are housed.
2. the in utero active birth control apparatus of animal according to claim 1 is characterized in that: the afterbody at V-arrangement nitinol alloy wire skeleton also is provided with a spacing divider through the tailfiber connection.
3. the in utero active birth control apparatus of animal according to claim 2 is characterized in that: equally copper sheathing is housed or/and tubulose pastille slow-release body at spacing divider cover.
4. the in utero active birth control apparatus of animal according to claim 1 is characterized in that: V-arrangement nitinol alloy wire skeleton is shuttle type framing structure or three-dimensional cup-shaped framing structure.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011201245991U CN202096333U (en) | 2011-04-26 | 2011-04-26 | In utero active contraceptive device for animal |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011201245991U CN202096333U (en) | 2011-04-26 | 2011-04-26 | In utero active contraceptive device for animal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN202096333U true CN202096333U (en) | 2012-01-04 |
Family
ID=45382372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011201245991U Expired - Fee Related CN202096333U (en) | 2011-04-26 | 2011-04-26 | In utero active contraceptive device for animal |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN202096333U (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150101613A1 (en) * | 2013-10-14 | 2015-04-16 | Contramed, Llc | Intrauterine device with controlled copper ion elution |
| US20150335465A1 (en) * | 2012-08-14 | 2015-11-26 | Contramed, Llc | Intrauterine contraceptive device |
| US10022264B2 (en) | 2013-10-18 | 2018-07-17 | Contramed, Llc | Intrauterine device with retrieval thread |
| US10159596B2 (en) | 2012-08-14 | 2018-12-25 | Sebela Vlc Limited | Intrauterine contraceptive device |
| US10918516B2 (en) | 2013-10-14 | 2021-02-16 | Sebela Vlc Limited | Intrauterine device with controlled copper ion elution |
-
2011
- 2011-04-26 CN CN2011201245991U patent/CN202096333U/en not_active Expired - Fee Related
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150335465A1 (en) * | 2012-08-14 | 2015-11-26 | Contramed, Llc | Intrauterine contraceptive device |
| US11850181B2 (en) | 2012-08-14 | 2023-12-26 | Sebela Vlc Limited | Intrauterine contraceptive device |
| US10159596B2 (en) | 2012-08-14 | 2018-12-25 | Sebela Vlc Limited | Intrauterine contraceptive device |
| US10166141B2 (en) | 2012-08-14 | 2019-01-01 | Sebela Vlc Limited | Intrauterine contraceptive device |
| US20190125576A1 (en) * | 2012-08-14 | 2019-05-02 | Sebela Vlc Limited | Intrauterine contraceptive device |
| US10932943B2 (en) | 2012-08-14 | 2021-03-02 | Sebela Vlc Limited | Intrauterine contraceptive device |
| US20210161703A1 (en) * | 2013-10-14 | 2021-06-03 | Sebela Vlc Limited | Intrauterine device with controlled copper ion elution |
| WO2015057291A1 (en) * | 2013-10-14 | 2015-04-23 | Contramed, Llc | Intrauterine device with controlled copper ion elution |
| US10188546B2 (en) | 2013-10-14 | 2019-01-29 | Sebela Vlc Limited | Intrauterine device with controlled copper ion elution |
| US20150101613A1 (en) * | 2013-10-14 | 2015-04-16 | Contramed, Llc | Intrauterine device with controlled copper ion elution |
| US10918516B2 (en) | 2013-10-14 | 2021-02-16 | Sebela Vlc Limited | Intrauterine device with controlled copper ion elution |
| US10398588B2 (en) | 2013-10-18 | 2019-09-03 | Sebela Vlc Limited | Intrauterine device with retrieval thread |
| US11207209B2 (en) | 2013-10-18 | 2021-12-28 | Sebela Vlc Limited | Intrauterine device with retrieval thread |
| US11744728B2 (en) | 2013-10-18 | 2023-09-05 | Sebela Vlc Limited | Intrauterine device with retrieval thread |
| US10022264B2 (en) | 2013-10-18 | 2018-07-17 | Contramed, Llc | Intrauterine device with retrieval thread |
| US12138199B2 (en) | 2013-10-18 | 2024-11-12 | Sebela Vlc Limited | Intrauterine device with retrieval thread |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN202096333U (en) | In utero active contraceptive device for animal | |
| CN203647443U (en) | Device for preventing adhesion of uterine cavity mucosa | |
| CA2596300A1 (en) | Intrauterine fallopian tube occlusion device and method for use | |
| EA037691B1 (en) | Device positionable in the uterine cavity | |
| CN201537164U (en) | Three-dimensional intrauterine active contraceptive device for animals | |
| Hartman | The period of gestation in the monkey, Macacus rhesus, first description of parturition in monkeys, size and behavior of the young | |
| CN205251812U (en) | Fang gong chamber adhesion birth control ware | |
| CN202044643U (en) | Drug membrane-covered stent for preventing and curing intrauterine adhesion | |
| CN201618299U (en) | Intrauterine medicine slow-release device | |
| CN201248795Y (en) | Condom with strong pleasant sensation | |
| CN205683181U (en) | Intrauterine device | |
| CN202724077U (en) | Intrauterine device with memory function | |
| CN204410942U (en) | A kind of artificial gravidity assisting device | |
| CN209629892U (en) | A kind of domestic animal uterus reset auxiliary therapeutic apparatus | |
| McLafferty et al. | Male and female reproductive systems and associated conditions | |
| CN204233272U (en) | With the condom of coronary sulcus tooth | |
| CN201912298U (en) | Intrauterine device (IUD) take-off device for gynaecology and obstetrics | |
| CN201920970U (en) | Levonorgestrel uterine cavity shape intrauterine device | |
| CN204446253U (en) | The condom of a kind of therapeutic indifference and psychosexual disorder | |
| CN203315161U (en) | Cylindrical cavernous body condom | |
| CN221731176U (en) | An intrauterine contraceptive device capable of increasing supporting force | |
| CN201182673Y (en) | Ring-fetching device for obstetrics and gynecology department | |
| CN203291100U (en) | Copper wire soft brush circular contraceptive ring | |
| CN203539510U (en) | Penis assist device | |
| WO2008138076A2 (en) | Device for animals and mode of operation of the detection methodology of the device to monitor, to report and to alarm changes of the intra - abdominal pressure by using communication technology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120104 Termination date: 20120426 |